Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Kordower, Jeffrey
PropertyValue
overview Other Appointments: Director, Section of Neurobiology Overview: Kordower is an international authority in the area of movement disorders with special expertise in pathophysiology and experimental therapeutic strategies in Parkinson’s disease, Alzheimer’s disease and Huntington’s disease — especially using nonhuman primate models. He has published landmark papers in the area of cell replacement strategies, including the first demonstration that fetal dopaminergic grafts can survive, innervate and form synapses in patients with Parkinson’s disease that was published in the New England Journal of Medicine. His recent demonstration that long-term grafts in such patients can form Lewy bodies was recently published in Nature Medicine. Kordower has published seminal studies including the lead article in Science demonstrating that gene delivery of the trophic factors GDNF and neurturin can prevent the emergence of motor symptoms and nigrostriatal degeneration in a monkey model of PD. He also was the first to demonstrate that gene delivery of trophic factors can obviate neurodegenerative processes in nonhuman primate models of Huntington’s disease and Alzheimer’s disease, with these studies being published in Nature and The Journal of Comparative Neurology, respectively. He has published numerous papers investigating the role of misfolded proteins in PD pathogenesis. These include papers in human and experimental PD on the role of alpha synuclein misfolding on Nurr1 and dopamine expression, lysosome and proteasome dysfunction, and axonal transport defects. He is a co-author on the landmark Nature paper lead by the Studer group demonstrating the structural and functional efficacy of dopaminergic human stem cells in rodent and nonhuman primate models of PD. In addition, he is collaborating with Trojanowski and Lee and recently demonstrated the ability of preformed fibrils to be transported in nonhuman primates and cause degeneration in nonhuman primates, a study that serves as the foundation of the current application. Kordower has published over 350 papers, has lectured all over the world, has been on over 20 editorial boards, and is on the SAB’s of many biotech companies and scientific organizations. He is a past councilor and past president of the American Society for Neural Transplantation, past chair for the Committee for the Use of Animals for SFN, and is a founding SAB member for the Michael J. Fox Foundation and is a past member of their Executive SAB. My Scopus ID is 7005337450. My NIH COMMONS name is JKORDOWER. Education PhD, Queens College, City University of New York MA, Queens College, City University of New York BA, Queens College, City University of New York
One or more keywords matched the following items that are connected to Kordower, Jeffrey
Item TypeName
Concept Dopamine Agents
Concept Dopamine Plasma Membrane Transport Proteins
Concept Dopamine
Concept Dopamine and cAMP-Regulated Phosphoprotein 32
Academic Article Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease.
Academic Article Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys.
Academic Article Decreased alpha-synuclein expression in the aging mouse substantia nigra.
Academic Article Nurr1 in Parkinson's disease and related disorders.
Academic Article Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
Academic Article Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates.
Academic Article Dopaminergic transplantation for Parkinson's disease: current status and future prospects.
Academic Article Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism.
Academic Article Age-related accumulation of Marinesco bodies and lipofuscin in rhesus monkey midbrain dopamine neurons: relevance to selective neuronal vulnerability.
Academic Article Age-related changes in glial cells of dopamine midbrain subregions in rhesus monkeys.
Academic Article AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's disease.
Academic Article Lewy body pathology in fetal grafts.
Academic Article Transplanted dopaminergic neurons develop PD pathologic changes: a second case report.
Academic Article Age and region-specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in monkeys.
Academic Article GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults.
Academic Article A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
Academic Article Neuropathology in transplants in Parkinson's disease: implications for disease pathogenesis and the future of cell therapy.
Academic Article Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration.
Academic Article Gene therapy for Parkinson's disease.
Academic Article Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.
Academic Article Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease.
Academic Article Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys.
Academic Article Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
Academic Article Transfer of host-derived a synuclein to grafted dopaminergic neurons in rat.
Academic Article Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats.
Academic Article Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease.
Academic Article Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra.
Academic Article Parkinsonian monkeys with prior levodopa-induced dyskinesias followed by fetal dopamine precursor grafts do not display graft-induced dyskinesias.
Academic Article Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In?Vivo.
Academic Article Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.
Academic Article Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's disease.
Academic Article Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes.
Academic Article Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson's Disease?
Academic Article Stem Cells: Scientific and Ethical Quandaries of a Personalized Approach to Parkinson's Disease.
Academic Article Mitomycin-C treatment during differentiation of induced pluripotent stem cell-derived dopamine neurons reduces proliferation without compromising survival or function in?vivo.
Academic Article Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson's disease.
Academic Article Nigral-specific increase in ser31 phosphorylation compensates for tyrosine hydroxylase protein and nigrostriatal neuron loss: Implications for delaying parkinsonian signs.
Search Criteria
  • Dopamine